Vytrus Biotech, the company specialized in active ingredients derived from plant biotechnology for the cosmetic industry, has agreed to come into a long-term alliance with the top K-Beauty manufacturer Cosmecca Korea to collaborate for future projects coming ahead.
Cosmecca Korea and Vytrus Biotech recently signed a commercial agreement to research on ingredients of cosmetic efficacy based on plant stem cell technology. The official meeting took place at Vytrus Biotech’s facilities near Barcelona (Spain) that gathered Daniel Robustillo (Sales Director of Vytrus Biotech) and Cho Hyun-hyun (Head of Technology of Cosmecca Korea) for the alliance signature.
This MOU agreement (Memorandum of Understanding) will enable both companies to combine the innovative and sustainable cutting-edge biotechnology of plant stem cell platforms of Vytrus Biotech with the high expertise in skincare R&D and manufacturing of Cosmecca Korea based on the latest K-Beauty trends.
According to Daniel Robustillo, Sales Director of Vytrus Biotech, “coming to an agreement with Cosmecca Korea is an opportunity for Vytrus Biotech to bring to the Korean market the best of European technology innovation in the cosmetic industry while integrating the outstanding and trending K-Beauty perspective of Cosmecca Korea into our future developments.”
Cosmecca Korea is a top ODM company in Korea, established in 1999 as an expert in R&D and manufacturing of skincare products, leading trends by reflecting consumer needs and collaborating with global client companies. The company is listed on the Korean stock market (KOSDAQ) and is present with its own facilities in South Korea, China and USA.
Vytrus’ innovations awarded at in-cosmetics Korea 2023
The active has been ranked third in the Best Ingredient Awards at the 2023 Korean edition, the leading trade fair for personal care ingredients in South Korea and a reference in the Asian continent. The awards ceremony took place on Wednesday, July 12 at the fair held in Seoul, South Korea, where the award was presented to the Vytrus Biotech sales team.
Following its recognition at the BSB Innovation Awards and placing among the top 10 finalists worldwide at the in-cosmetics Global Innovation Awards in March, this award for Photobiome™ in the land of K-Beauty trends reinforces its positioning among the latest innovations launched on the market. The in-cosmetics Korea 2023 fair annually brings together the major key players in the value chain of the cosmetics industry on the Asian continent and sets the main cosmetic trends worldwide. It is the 5th country in the world that exports the most cosmetic products, reaching 8.5 billion dollars in 2021 and being a gateway to important markets such as China and Japan. Vytrus Biotech is present in the main Asian markets and in 2022 increased its sales in this geographic area by 29%.
The new active Photobiome™ opens the door to a new category of Microbial Antioxidants by helping our skin microbiota photoprotect itself by protecting and nourishing bacteria, modulating the release of its own natural photo-defense molecules that improves the signs of the photoageing process on the skin.
